Bioventus Inc. (BVS)

Market Cap	180.84M
Revenue (ttm)	510.62M
Net Income (ttm)	-283.01M
Shares Out	62.79M
EPS (ttm)	-4.58
PE Ratio	n/a
Forward PE	64.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,072
Open	2.94
Previous Close	2.93
Day's Range	2.82 - 3.00
52-Week Range	0.80 - 8.29
Beta	0.33
Analysts	Hold
Price Target	4.17 (+44.79%)
Earnings Date	Nov 7, 2023

About BVS

Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices used for pr...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 11, 2021
• Employees: 950
• Stock Exchange: NASDAQ
• Ticker Symbol: BVS

Analyst Forecast

According to 5 analysts, the average rating for BVS stock is "Hold." The 12-month stock price forecast is $4.17, which is an increase of 44.79% from the latest price.

Price Target

$4.17

(44.79% upside)

Analyst Consensus: Hold